Acceptability of OraQuick Advance© Rapid HIV-1/2 Antibody screening
BehavioralOral fluid-based HIV test
NCT Number: NCT04774666
The purpose of this study is to evaluate the acceptability, feasibility and effectiveness of a caregiver-assisted oral fluid-based HIV test to screen children for HIV. The results of this study are intended to support expanded access to HIV testing and treatment services for children, and to ensure that all newly diagnosed children are linked to clinical care.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Bugiri Hospital, Bugiri, Bugiri District, Uganda
Rationale: Globally, there are 1.8 million children living with HIV (CLHIV), however, despite great progress over the past 15 years, only 52% are receiving antiretroviral therapy (ART), leaving approximately 864,000 children in need of treatment.1 Pediatric case finding is the first, critical step to close the pediatric ART gap. In Uganda, there are an estimated 36,873 CLHIV in need of HIV treatment.2 Reaching this population is challenging, because children are dependent on parents and caregivers to access HIV testing services. Parents and caregivers often face logistical, societal and other barriers that limit the uptake of testing services for children. In order to achieve the second and third UNAIDS 95 targets for pediatric HIV treatment coverage and viral load suppression to reach epidemic control, country programs need to utilize increasingly targeted and innovative testing modalities to optimize the identification CLHIV. Oral fluid-based screening may present a safe, convenient and reliable way to identify CLHIV that can expand access to essential testing services in resource-limited settings where most CLHIV reside.
Methods: The study will use a cross-sectional cluster sampling design, in which 32 facilities in 16 districts will be selected using probability-proportional-to-size (PPS) sampling. In the 32 selected facilities, index parent/caregivers of approximately 4,687 children will be recruited to accept test kits for their children. Adult index parent/caregivers will be consented to participate in the study and asked for parental permission for their child(ren) to participate, given a number of oral screening kits corresponding to the number of children eligible for screening, and followed-up to confirm the oral fluid-based screening results and participate in a testing experience survey. Any children who screen HIV reactive will receive confirmatory testing and active linkage to care and treatment services. A cost analysis which includes savings associated with facility or home-based costs averted, using existing sources to estimate the costs of facility-based testing and home-based by a community health worker (CHW), preferably from antenatal settings will be undertaken.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Index parent/caregivers:
Inclusion criteria
for eligible children:
Inclusion criteria
for participation in survey after completion of care giver-assisted oral fluid-based HIV screening:
Exclusion criteria
for Index parent/caregivers:
Exclusion criteria
for eligible children:
Exclusion criteria
for participation in survey after completion of oral-based HIV screening:
Oral fluid-based HIV test
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Comparative costs between oral fluid-based screening and the costs of the existing referral to testing program, from the perspective of the health care provider.
Catholic Relief Services
Other
Caregiver-Assisted Oral Fluid-based HIV Screening in Children: Estimation of Acceptability, Feasibility and Effectiveness Linked to Index Testing Services in Uganda
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07074899
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Lima, Lima Province, Peru
View Trial DetailsNCT06969677
HIV Stigma, HIV Testing
Mbarara, Uganda
View Trial DetailsNCT05306938
Behavior, Contraception Behavior
Dar es Salaam, Tanzania
View Trial DetailsNCT07165496
Behavior, HIV Testing
Lima, Lima Province, Peru
View Trial Details